LivaNova PLC (NASDAQ:LIVN) was downgraded by stock analysts at WBB Securities from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, The Fly reports.

Other analysts have also recently issued research reports about the stock. Berenberg Bank reaffirmed a “buy” rating and set a $70.00 target price on shares of LivaNova PLC in a research note on Friday. BidaskClub lowered shares of LivaNova PLC from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. One analyst has rated the stock with a sell rating, three have given a hold rating and one has issued a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $61.33.

Shares of LivaNova PLC (NASDAQ:LIVN) opened at 62.25 on Tuesday. LivaNova PLC has a 12 month low of $40.83 and a 12 month high of $64.95. The firm has a market cap of $3.04 billion, a PE ratio of 111.16 and a beta of 0.62. The firm has a 50 day moving average price of $61.63 and a 200-day moving average price of $55.29.

LivaNova PLC (NASDAQ:LIVN) last issued its earnings results on Wednesday, August 9th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.82 by $0.19. The business had revenue of $321.40 million during the quarter, compared to the consensus estimate of $315.75 million. LivaNova PLC had a net margin of 2.26% and a return on equity of 9.08%. The firm’s revenue for the quarter was up .1% compared to the same quarter last year. On average, analysts predict that LivaNova PLC will post $3.16 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This story was first reported by Watch List News and is the sole property of of Watch List News. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://www.watchlistnews.com/wbb-securities-lowers-livanova-plc-livn-to-sell/1489947.html.

In other news, Director Daniel Jeffrey Moore sold 1,000 shares of the stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $61.55, for a total transaction of $61,550.00. Following the completion of the transaction, the director now directly owns 56,437 shares of the company’s stock, valued at approximately $3,473,697.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have sold a total of 3,000 shares of company stock valued at $180,840 over the last three months. Insiders own 0.28% of the company’s stock.

A number of hedge funds have recently bought and sold shares of the company. Mason Street Advisors LLC boosted its stake in LivaNova PLC by 0.3% in the first quarter. Mason Street Advisors LLC now owns 20,484 shares of the company’s stock valued at $1,004,000 after buying an additional 64 shares during the period. Louisiana State Employees Retirement System raised its position in LivaNova PLC by 0.9% in the first quarter. Louisiana State Employees Retirement System now owns 10,900 shares of the company’s stock valued at $534,000 after buying an additional 100 shares in the last quarter. PNC Financial Services Group Inc. raised its position in LivaNova PLC by 9.8% in the second quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock valued at $105,000 after buying an additional 153 shares in the last quarter. Advantus Capital Management Inc raised its position in LivaNova PLC by 3.3% in the first quarter. Advantus Capital Management Inc now owns 5,551 shares of the company’s stock valued at $272,000 after buying an additional 176 shares in the last quarter. Finally, Oregon Public Employees Retirement Fund raised its position in LivaNova PLC by 1.3% in the first quarter. Oregon Public Employees Retirement Fund now owns 15,360 shares of the company’s stock valued at $753,000 after buying an additional 200 shares in the last quarter. Institutional investors and hedge funds own 75.01% of the company’s stock.

About LivaNova PLC

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

The Fly

Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.